bendamustine
nouscom,janssen
['solid tumor', 's209', 'nouscom']
full clinical data set from the ph1 trial of our lead candidate, nous-209, an 'off-the-shelf' immunotherapy for the treatment of dmmr/msi-h solid tumors, was presented at american society of clinical oncology (asco) annual meeting on 5 june 2022. #nouscom #asco22 #nous209 